Changes related to "Cyclophosphamide (Cytoxan)"

Jump to: navigation, search

This is a list of changes made recently to pages linked from a specified page (or to members of a specified category). Pages on your watchlist are bold.

Recent changes options
Legend:
N
This edit created a new page (also see list of new pages)
m
This is a minor edit
b
This edit was performed by a bot
(±123)
The page size changed by this number of bytes
Show last 50 | 100 | 250 | 500 changes in last 1 | 3 | 7 | 14 | 30 days
Hide minor edits | Show bots | Hide anonymous users | Hide registered users | Hide my edits

Show new changes starting from 20:27, 16 December 2018
   
Page name:

16 December 2018

     20:00  Breast cancer‎‎ (8 changes | history) . . (+8,447). . [Jwarner‎ (8×)]
      20:00 (cur | prev) . . (+1,759). . Jwarner (talk | contribs) (Docetaxel monotherapy {{#subobject:1216fd|Regimen=1}})
 m    19:55 (cur | prev) . . (+2). . Jwarner (talk | contribs)
 m    18:01 (cur | prev) . . (+996). . Jwarner (talk | contribs) (FEC {{#subobject:3613b7|Regimen=1}})
      14:40 (cur | prev) . . (+1,658). . Jwarner (talk | contribs) (Doxorubicin pegylated liposomal monotherapy {{#subobject:2b08a6|Regimen=1}})
 m    12:44 (cur | prev) . . (+828). . Jwarner (talk | contribs) (Docetaxel & Bevacizumab {{#subobject:65222f|Regimen=1}})
 m    10:51 (cur | prev) . . (+643). . Jwarner (talk | contribs) (References)
      10:45 (cur | prev) . . (+1,661). . Jwarner (talk | contribs) (EC {{#subobject:3e1e8f|Regimen=1}})
 m    10:01 (cur | prev) . . (+900). . Jwarner (talk | contribs) (Capecitabine & Docetaxel {{#subobject:9d5b30|Regimen=1}})
 m   18:05  Prostate cancer‎ (diff | hist) . . (+860). . Jwarner (talk | contribs) (Intermittent ADT)
     14:31  Anaplastic large cell lymphoma‎ (diff | hist) . . (+1,420). . Jwarner (talk | contribs) (BV-CHP {{#subobject:6964de|Regimen=1}})

15 December 2018

     22:51  Breast cancer‎‎ (5 changes | history) . . (+13,632). . [Jwarner‎ (5×)]
 m    22:51 (cur | prev) . . (+827). . Jwarner (talk | contribs) (FEC {{#subobject:3613b7|Regimen=1}})
 m    22:15 (cur | prev) . . (+8,722). . Jwarner (talk | contribs)
 m    19:51 (cur | prev) . . (+959). . Jwarner (talk | contribs) (Paclitaxel monotherapy, q3wk {{#subobject:3e5448|Regimen=1}})
 m    19:27 (cur | prev) . . (+826). . Jwarner (talk | contribs) (iddEPC {{#subobject:28ad40|Regimen=1}})
      19:23 (cur | prev) . . (+2,298). . Jwarner (talk | contribs) (EC {{#subobject:8d8dbe|Regimen=1}})
 m   21:03  Prostate cancer‎ (diff | hist) . . (+873). . Jwarner (talk | contribs) (ADT {{#subobject:45fc98|Regimen=1}})
 m   18:37  B-cell acute lymphoblastic leukemia‎‎ (3 changes | history) . . (+2,069). . [Jwarner‎ (3×)]
 m    18:37 (cur | prev) . . (+2,782). . Jwarner (talk | contribs) (Daunorubicin, L-Asparaginase, Vincristine, Prednisone {{#subobject:3c9897|Regimen=1}})
 m    17:42 (cur | prev) . . (-744). . Jwarner (talk | contribs) (References)
 m    09:03 (cur | prev) . . (+31). . Jwarner (talk | contribs) (Daunorubicin, L-Asparaginase, Vincristine, Prednisone {{#subobject:3c9897|Regimen=1}})
 m   17:13  Chronic lymphocytic leukemia (CLL/SLL)‎ (diff | hist) . . (+519). . Jwarner (talk | contribs) (References)
 m   17:05  Diffuse large B-cell lymphoma‎ (diff | hist) . . (+622). . Jwarner (talk | contribs) (References)
 m   16:26  Acute myeloid leukemia‎‎ (3 changes | history) . . (+2,347). . [Jwarner‎ (3×)]
 m    16:26 (cur | prev) . . (+1,452). . Jwarner (talk | contribs) (ADE (standard-dose Ara-C) {{#subobject:e221d7|Regimen=1}})
 m    09:01 (cur | prev) . . (+31). . Jwarner (talk | contribs) (HiDAC {{#subobject:caa3a2|Regimen=1}})
 m    09:00 (cur | prev) . . (+864). . Jwarner (talk | contribs) (7+3d (standard-dose) {{#subobject:9f31ad|Regimen=1}})
 m   09:22  Small cell lung cancer‎ (diff | hist) . . (+31). . Jwarner (talk | contribs) (CEV & RT {{#subobject:a3e998|Regimen=1}})

14 December 2018

 m   22:18  Osteosarcoma‎ (diff | hist) . . (+850). . Jwarner (talk | contribs) (Cisplatin & Doxorubicin {{#subobject:418c69|Regimen=1}})
 m   17:05  Acute myeloid leukemia‎‎ (2 changes | history) . . (+1,200). . [Jwarner‎ (2×)]
 m    17:05 (cur | prev) . . (+641). . Jwarner (talk | contribs) (7+3d (standard-dose) {{#subobject:9f31ad|Regimen=1}})
 m    16:58 (cur | prev) . . (+559). . Jwarner (talk | contribs) (7+3d (standard-dose) {{#subobject:9f31ad|Regimen=1}})
 m   10:35  B-cell acute lymphoblastic leukemia‎‎ (2 changes | history) . . (+12). . [Jwarner‎ (2×)]
 m    10:35 (cur | prev) . . (+12). . Jwarner (talk | contribs) (POMP {{#subobject:31219|Regimen=1}})
 m    10:31 (cur | prev) . . (0). . Jwarner (talk | contribs) (POMP {{#subobject:31219|Regimen=1}})

13 December 2018

 m   22:18  Breast cancer‎ (diff | hist) . . (+7,116). . Jwarner (talk | contribs)
 m   10:42  Acute myeloid leukemia‎ (diff | hist) . . (+960). . Jwarner (talk | contribs) (7+3i {{#subobject:717935|Regimen=1}})

12 December 2018

 m   14:37  Acute myeloid leukemia‎‎ (4 changes | history) . . (+2,402). . [Jwarner‎ (4×)]
 m    14:37 (cur | prev) . . (+899). . Jwarner (talk | contribs) (Observation)
 m    12:57 (cur | prev) . . (+106). . Jwarner (talk | contribs) (7+3m {{#subobject:240c72|Regimen=1}})
 m    12:28 (cur | prev) . . (+736). . Jwarner (talk | contribs) (Observation)
 m    12:20 (cur | prev) . . (+661). . Jwarner (talk | contribs) (Observation)
 m   11:44  Ewing's sarcoma‎‎ (2 changes | history) . . (+2,207). . [Jwarner‎ (2×)]
 m    11:44 (cur | prev) . . (+76). . Jwarner (talk | contribs)
 m    11:43 (cur | prev) . . (+2,131). . Jwarner (talk | contribs) (EVAIA {{#subobject:a56448|Regimen=1}})
     09:05  Small cell lung cancer‎‎ (3 changes | history) . . (+4,022). . [Jwarner‎ (3×)]
 m    09:05 (cur | prev) . . (+8). . Jwarner (talk | contribs) (Carboplatin, Etoposide, Atezolizumab {{#subobject:760b97|Regimen=1}})
 m    09:04 (cur | prev) . . (+1,503). . Jwarner (talk | contribs) (Bevacizumab monotherapy {{#subobject:e2a180|Regimen=1}})
      09:02 (cur | prev) . . (+2,511). . Jwarner (talk | contribs) (Carboplatin & Etoposide {{#subobject:de3ba6|Regimen=1}})

11 December 2018

 m   21:42  Ewing's sarcoma‎ (diff | hist) . . (+220). . Jwarner (talk | contribs)
 m   17:15  Acute myeloid leukemia‎‎ (2 changes | history) . . (+1,785). . [Jwarner‎ (2×)]
 m    17:15 (cur | prev) . . (+943). . Jwarner (talk | contribs) (7+3d (standard-dose) {{#subobject:9f31ad|Regimen=1}})
 m    14:54 (cur | prev) . . (+842). . Jwarner (talk | contribs) (Observation)

10 December 2018

 m   22:41  Prostate cancer‎ (diff | hist) . . (+2,227). . Jwarner (talk | contribs)
 m   15:52  B-cell acute lymphoblastic leukemia‎‎ (2 changes | history) . . (+1,889). . [Jwarner‎ (2×)]
 m    15:52 (cur | prev) . . (+1,010). . Jwarner (talk | contribs) (Etoposide & TBI, then allo HSCT {{#subobject:b389e1|Regimen=1}})
 m    14:40 (cur | prev) . . (+879). . Jwarner (talk | contribs) (Cyclophosphamide & TBI, then allo HSCT {{#subobject:a9e6e8|Regimen=1}})
 m   15:44  Follicular lymphoma‎ (diff | hist) . . (0). . Jwarner (talk | contribs)
 m   15:26  Hodgkin lymphoma‎‎ (2 changes | history) . . (+1,691). . [Jwarner‎ (2×)]
 m    15:26 (cur | prev) . . (+1,112). . Jwarner (talk | contribs) (Flu-Mel, then allo HSCT {{#subobject:6f8499|Regimen=1}})
 m    13:06 (cur | prev) . . (+579). . Jwarner (talk | contribs) (MOPP {{#subobject:bcde0|Regimen=1}})